AAAAAA

   
Results: << | 101-125 | 126-150 | 151-175 | 176-200 | >>

Table of contents of journal: *Molecular medicine today (Regular ed.)

Results: 101-125/784

Authors: Wenger, DA
Citation: Da. Wenger, Murine, canine and non-human primate models of Krabbe disease, MOL MED TOD, 6(11), 2000, pp. 449-451

Authors: Rooke, K
Citation: K. Rooke, Changing Trends, MOL MED TOD, 6(10), 2000, pp. 375-375

Authors: Greener, M
Citation: M. Greener, Targeting TGF could counter diabetic nephropathy, MOL MED TOD, 6(10), 2000, pp. 376-376

Authors: Habeck, M
Citation: M. Habeck, Kaposi's sarcoma-associated virus mounts novel attack on immune system, MOL MED TOD, 6(10), 2000, pp. 377-377

Authors: Bradbury, J
Citation: J. Bradbury, Vaccine against breast and ovarian cancer still on the horizon, MOL MED TOD, 6(10), 2000, pp. 378-378

Authors: Fricker, J
Citation: J. Fricker, Another piece in the hypertension puzzle, MOL MED TOD, 6(10), 2000, pp. 378-379

Authors: Wanker, EE
Citation: Ee. Wanker, Protein aggregation in Huntington's and Parkinson's disease: implications for therapy, MOL MED TOD, 6(10), 2000, pp. 387-391

Authors: Citron, M
Citation: M. Citron, Secretases as targets for the treatment of Alzheimer's disease, MOL MED TOD, 6(10), 2000, pp. 392-397

Authors: Kloog, Y Cox, AD
Citation: Y. Kloog et Ad. Cox, RAS inhibitors: potential for cancer therapeutics, MOL MED TOD, 6(10), 2000, pp. 398-402

Authors: Leonard, WJ
Citation: Wj. Leonard, X-linked severe combined immunodeficiency: from molecular cause to gene therapy within seven years, MOL MED TOD, 6(10), 2000, pp. 403-407

Authors: Tietze, MK Chin, L
Citation: Mk. Tietze et L. Chin, Murine models of malignant melanoma, MOL MED TOD, 6(10), 2000, pp. 408-410

Authors: Sansom, C
Citation: C. Sansom, FISHing for aneuploidies nets accurate results, MOL MED TOD, 6(1), 2000, pp. 1-1

Authors: Senior, K
Citation: K. Senior, Cancer research explosion imminent, MOL MED TOD, 6(1), 2000, pp. 2-3

Authors: Greener, M
Citation: M. Greener, PANDA identifies babies at risk of developing type 1 diabetes, MOL MED TOD, 6(1), 2000, pp. 3-3

Authors: Habeck, M
Citation: M. Habeck, Dissecting the risk factors for pre-eclampsia, MOL MED TOD, 6(1), 2000, pp. 4-4

Authors: Novelli, G Amati, F Dallapiccola, B
Citation: G. Novelli et al., Individual haploinsufficient loci and the complex phenotype of DiGeorge syndrome, MOL MED TOD, 6(1), 2000, pp. 10-11

Authors: Baldini, A
Citation: A. Baldini, DiGeorge syndrome: complex pathogenesis? Maybe, maybe not, MOL MED TOD, 6(1), 2000, pp. 12-12

Authors: Srivastava, D
Citation: D. Srivastava, DiGeorge syndrome: an enigma in mice and men, MOL MED TOD, 6(1), 2000, pp. 13-14

Authors: Goodship, JA Burn, J
Citation: Ja. Goodship et J. Burn, UFD1L is not the monogenic basis for heart defects associated with the CATCH phenotype, MOL MED TOD, 6(1), 2000, pp. 14-14

Authors: Stubbs, M McSheehy, PMJ Griffiths, JR Bashford, CL
Citation: M. Stubbs et al., Causes and consequences of tumour acidity and implications for treatment, MOL MED TOD, 6(1), 2000, pp. 15-19

Authors: Rankin, SM Conroy, DM Williams, TJ
Citation: Sm. Rankin et al., Eotaxin and eosinophil recruitment: implications for human disease, MOL MED TOD, 6(1), 2000, pp. 20-27

Authors: Hewson, R
Citation: R. Hewson, RNA viruses: emerging vectors for vaccination and gene therapy, MOL MED TOD, 6(1), 2000, pp. 28-35

Authors: Macchia, PE
Citation: Pe. Macchia, Recent advances in understanding the molecular basis of primary congenitalhypothyroidism, MOL MED TOD, 6(1), 2000, pp. 36-42

Authors: Gainetdinov, RR Caron, MG
Citation: Rr. Gainetdinov et Mg. Caron, An animal model of attention deficit hyperactivity disorder, MOL MED TOD, 6(1), 2000, pp. 43-44

Authors: Senior, K
Citation: K. Senior, Germline gene transfer during gene therapy: reassessing the risks, MOL MED TOD, 5(9), 1999, pp. 371-371
Risultati: << | 101-125 | 126-150 | 151-175 | 176-200 | >>